Black Patients with Lupus Face Significantly Greater Cardiovascular Risks
New findings show a unique series of markers could indicate particular black SLE patient risks.
Apremilast Provides One-Year Psoriatic Arthritis Benefit, Regardless of Treatment History
A real-world study shows the therapy was slightly more efficacious for biologic-naive PsA patients.
Methotrexate Use Linked to Greater Tuberculosis Risks
The common rheumatic drug was found in a cohort analysis to be linked to greater regional TB outbreaks.
Osteoporosis Rarely Diagnosed, Treated Among Older Men with Fractures
Just 2% of observed older men to experience an indicative fracture received a diagnosis and treatment for osteoporosis over a four-year period.
Rheumatic Patients in Africa, Asia Faced Hydroxychloroquine Shortage due to COVID-19
New survey findings show the antimalarial drug's promotion for potential SARS-CoV-2 benefit early into the pandemic led to needing patients losing access.
